Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Open accessThe DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index; none of the 131 sources its claims cite is checked for support yet.
Abstract
Pseudomonas aeruginosa is a major cause of life-threatening acute infections and life-long lasting chronic infections. The characteristic biofilm mode of life in P. aeruginosa chronic infections severely limits the efficacy of antimicrobial therapies, as it leads to intrinsic tolerance, involving physical and physiological factors in addition to biofilm-specific genes that can confer a transient protection against antibiotics promoting the development of resistance. Indeed, a striking feature of this pathogen is the extraordinary capacity to develop resistance to nearly all available antibiotics through the selection of chromosomal mutations, evidenced by its outstanding and versatile mutational resistome. This threat is dramatically amplified in chronic infections, driven by the frequent emergence of mutator variants with enhanced spontaneous mutation rates. Thus, this mini review is focused on describing the complex interplay of antibiotic resistance mechanisms in P. aeruginosa biofilms, to provide potentially useful information for the design of effective therapeutic strategies.
Overview
CoChat Summary
TL;DR
This mini-review describes how *Pseudomonas aeruginosa* biofilms combine transient antibiotic tolerance mechanisms with conventional resistance mechanisms, including mutational resistance and horizontal gene transfer. It argues that biofilm physiology and population structure create a favorable environment for resistance emergence and discusses therapeutic strategies targeting biofilm-specific vulnerabilities.
Key findings
- Biofilm tolerance involves matrix binding/penetration delay, nutrient and oxygen gradients, low metabolic activity, persisters (<0.1% of the biofilm population), reduced ROS, upregulated efflux pumps, and adaptive responses such as colistin-induced *pmr*/*arn* and β-lactam-induced AmpC; these confer transient protection rather than conventional resistance.
- Conventional resistance in biofilms includes mutational resistance and horizontal gene transfer. Mutator/hypermutable strains are present in over one-third of studied cystic fibrosis patients with chronic respiratory infections, compared with 10% at chronic infection onset, 6% in the environment, and <1% in acute infections.
- Biofilm-specific gene expression contributes to resistance: *brlR* activates MexAB-oprM and MexEF-oprN efflux pumps and the ABC transporter PA1874-1877 (10 times more expressed in biofilms), and increased *brlR* lowered susceptibility to hydrogen peroxide and five different classes of antibiotics, increasing MICs up to 6-fold.
- Biofilms facilitate horizontal gene transfer via conjugation, transformation, and transduction; conjugation occurs at higher frequencies than in planktonic cultures, and biofilms can act as plasmid reserves preserving multidrug-resistance plasmids. Mixed biofilm communities also show shielding, e.g., PAO1Δ*dacB* resistant mutants were selected for and amplified under cefepime and located in outer biofilm layers surrounding sensitive PAO1.
Methods
- Design: narrative mini-review; no primary experiments or systematic review methodology are reported.
- Data or sample: published literature on *P. aeruginosa* biofilms, antibiotic tolerance/resistance mechanisms, and related in vitro, in vivo, and cystic fibrosis clinical studies; no new sample or dataset is generated.
- Main analysis: synthesis of cited studies and mechanisms, including a figure adapted from Ciofu et al., *Nat Rev*, 2022.
Limitations
- The paper states no limitations.
- Evident: as a mini-review, it lacks systematic search/selection criteria and does not report primary data or quantitative synthesis.
- Evident: its scope is restricted to *P. aeruginosa* biofilms and antibiotic resistance/tolerance mechanisms; the therapeutic strategies discussed are not clinically validated in this paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 3 Not valid · 75 Not checked · 10 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“The characteristic biofilm mode of life in P. aeruginosa chronic infections severely limits the efficacy of antimicrobial therapies, as it leads to intrinsic tolerance”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Abstract
What the sources say
- Not checked yetcites [5] Høiby N. Ciofu O. Johansen H.K. Song Z. Moser C. Jensen P.Ø. The clinical impact of bacterial biofilms Int J Oral Sci 3 2011 55 65 10.4248/IJOS11026 21485309 PMC3469878 source
- Not checked yetcites [6] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob Agents Chemother 55 2011 4469 4474 10.1128/AAC.00126-11 21670181 PMC3165294 source
- Not checked yetcites [7] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection Antimicrob Agents Chemother 56 2012 2683 2690 10.1128/AAC.06486-11 22354300 PMC3346607 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“promoting the development of resistance”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Due to the matrix protection, bacterial cells within a biofilm are significantly more recalcitrant to antibiotics and host immune defences than their planktonic counterparts, as shown by in vitro and in vivo evidence [[5], [6], [7], [8]].”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction
What the sources say
- Not checked yetcites [5] Høiby N. Ciofu O. Johansen H.K. Song Z. Moser C. Jensen P.Ø. The clinical impact of bacterial biofilms Int J Oral Sci 3 2011 55 65 10.4248/IJOS11026 21485309 PMC3469878 source
- Not checked yetcites [6] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob Agents Chemother 55 2011 4469 4474 10.1128/AAC.00126-11 21670181 PMC3165294 source
- Not checked yetcites [7] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection Antimicrob Agents Chemother 56 2012 2683 2690 10.1128/AAC.06486-11 22354300 PMC3346607 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“which by itself is intrinsically resistant to many antibiotics”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction > Pseudomonas aeruginosa: a paradigmatic microorganism
What the sources say
- Not checked yetcites [15] Potron A. Poirel L. Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology Int J Antimicrob Agents 45 2015 568 585 10.1016/j.ijantimicag.2015.03.001 25857949 source
- Not checked yetcites [16] Oliver A. Mulet X. López-Causapé C. Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones Drug Resist Updates 21–22 2015 41 59 10.1016/j.drup.2015.08.002 26304792 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“the inability to clear the bacteria is directly related to the chronicity of the infections [9,10].”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction
What the sources say
- Not checked yetcites [9] Smith E.E. Buckley D.G. Wu Z. Saenphimmachak C. Hoffman L.R. D’Argenio D.A. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients Proc Natl Acad Sci U S A 103 2006 8487 8492 10.1073/pnas.0602138103 16687478 PMC1482519 source
- Not checked yetcites [10] Oliver A. Mena A. Maciá M.D. Evolution of Pseudomonas aeruginosa pathogenicity: from acute to chronic infections Evol. Biol. Bact. Fungal pathog 2007 John Wiley & Sons, Ltd 433 444 10.1128/9781555815639.ch36 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
48 more claims
Create a free account to see all 88 claims and to verify the 131 references still open.
- It may state two separate claims as one. 30
- Probably not a substantial claim. 9
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Biofilms as Complex Differentiated Communities
Stoodley, P., Sauer, K., Davies, D. G., & Costerton, J. W. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160705 · Cited by 3,158
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203 · cited 1×
“in turn activates DNA release systems further promoting said state, that also contribute to the stabilisation of the biofilm matrix [77,99,104].”
BackgroundSurvival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
Bacterial biofilm and associated infections
Jamal, M., Ahmad, W., Andleeb, S., Jalil, F., Imran, M., Nawaz, M. A., Hussain, T., Ali, M., Rafiq, M., & Kamil, M. A. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.07.012 · Cited by 1,642
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Self-citation
Cited by
Items 101–170 of 170
Nanotechnology-based strategies for environmental control of antimicrobial resistance
Mehta, D., & Singh, S. (2026) · Environmental Science Nano · doi:10.1039/d6en00454g · Cited by 1
Ahmed, N. K., Hamza, D. A., Awaad, S. S., Abdel-Salam, A. B., & Sallam, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-57335-2 · Cited by 1
Molecular epidemiology of Pseudomonas aeruginosa in Africa: A systematic review and Meta-analysis
Osei-Kuffour, N. S., Duah, F., Kungu, F., Ntim, O. K., & Donkor, E. S. (2026) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2026.105959 · Cited by 1
Anantharaman, S., Fu, J., & Boon, E. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.03.662950 · Cited by 1
Analysis of Gene Expression Linked to Efflux Pumps and Porins in Pseudomonas aeruginosa IsolatesPreprint
Rahi, A. A. (2024) · Research Square · doi:10.21203/rs.3.rs-5511490/v1 · Cited by 1
White, B., & Bose, S. (2026) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.70160
Physiologic manipulation of microalgae-bacteria consortia: chances and limitationsPreprint
Hering-Peter, C., & Schulz, R. (2025) · Research Square · doi:10.21203/rs.3.rs-6410592/v1
Physiological responses of floc-forming microalgae-bacteria consortia to environmental perturbations
Hering-Peter, C., & Schulz, R. (2026) · Bioresource Technology · doi:10.1016/j.biortech.2026.135341
From Chronic Infection to Microbial Imbalance: Rethinking Chronic Rhinosinusitis
Łabaz, J. P., Guth, M., Kaleta, J. S., Kaczmarek, J., Kinczel, M., Kornak, K., Kaczor, M., Leszczyszyn, A., Dorobisz, K., & Pazdro-Zastawny, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209170
Abeydeera, N., Pant, B. D., & Chen, G. (2026) · Antibiotics · doi:10.3390/antibiotics15100975
Al-Ani, A. W., Tawfeeq, H. K., Saad‐allah, N. Q., & Lafta, F. M. (2026) · ChemistrySelect · doi:10.1002/slct.202506175
Resistome, virulome and phage defense systems of a hypervirulent XDR Pseudomonas aeruginosa ST357
Santos, A. M., Camargo, C. H., Yamada, A. Y., Campos, K. R., Sacchi, C. T., Vila, M. M. D. C., & Balcão, V. M. (2026) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen8405
Sugiaman, V. K., Prahastuti, S., Jeffrey, J., Widowati, W., Ayuni, V., & Hadiprasetyo, D. S. (2026) · Natural Resources for Human Health · doi:10.53365/nrfhh/211488
Saccomori, E., Amarante, B. A., dos Santos, P. P., & Priamo, W. L. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100615
Ghahremanpour, H., Abadi, A. T. B., & Fooladi, A. A. I. (2026) · Archives of Medical Research · doi:10.1016/j.arcmed.2026.103479
Eurobiofilms 2022: A translational perspective of biofilm-related persistent infections
Macia, M. D., Borghi, E., & Oliver, A. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100168
Self-citation(2025) · Microbiology Australia · doi:10.1071/mav46n4
Parit, S. D., Mane, P. M., & Patil, S. R. (2026) · Cureus · doi:10.7759/cureus.116262
Jabar, Z. D., Sanyi, R. H. H., & Hameed, F. R. (2026) · Al-Turath Medical Journal · doi:10.63964/atmj.2026.2.3.12
Hibernation factors and ribosomal dynamics of dormancy in Pseudomonas aeruginosa
Kanik, M. (2025) · Montana State University ScholarWorks (Montana State University)
Muddassir, M., Shozeb, W., Sajjad, A., Munir, S., & Basirat, A. (2025) · Chronicles of Biomedical Sciences
Mise au point de biopiles microbiennes
Votat, S. (2023) · theses.fr (ABES) · doi:10.70675/8b132489z2526z49bczad51z8c536503fe52
de Souza, T. A. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Morales-Quezada, N. D. C., & Arbaiza-Arana, B. D. (2026) · CIENCIAMATRIA · doi:10.35381/cm.v12i2.2362
Influence of Non-Tuberculous Bacterial Infection on Prognosis of HemoptysisPreprint
Wei, F. A. N., Chang, Y.-W., & Wang, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4906671
Jha, K. A., & Sharda, K. (2026) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20260426
Ciszkowicz, E., Marczak, B., Buczkowicz, J., Lecka-Szlachta, K., Sikora, K., Kamysz, W., Anderluh, G., Filipič, K. E., Zavec, A. B., Bonarek, P., et al. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.118112
Pejčić Pejić, M. G. (2024) · National Repository of Dissertations in Serbia
Agent-based modeling of erosion and sloughing during growth of Pseudomonas aeruginosa biofilms
Bournes, R., Hingley‐Wilson, S., Guo, B., Harris, C., Abubacar, U., Chambers, M. A., & Bauer, R. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01052-1
Pseudomonas Aeruginosa’da İntrinsik Antimikrobiyal Direnç Mekanizmaları
KÜRKÇÜ, M. F. (2026) · Bidge Yayınları eBooks · doi:10.70269/10.70269/2155274465
Akram, S., Salka, K., Jatmiko, Y. D., Suyadi, S., Novianti, I., & Nurgiartiningsih, V. M. A. (2026) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2026/14.12.2689.2709
Riyanto, B., Rahmawati, I., & Sunarni, T. (2026) · JI-KES (Jurnal Ilmu Kesehatan) · doi:10.33006/ji-kes.v10i1.1046
Shehata, Z. E., Al‐Daghistani, H. I., & Atoom, A. M. (2026) · Pathogens · doi:10.3390/pathogens15111172
Poniatovskyi, V. A., Vodianyk, A. A., Shyrobokov, V. P., & Kharina, A. V. (2025) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2025.5.338971
Ageba, S. L., Orole, O. O., Uyi, G., Muhammad, M. H., & Gbadeyan, F. (2026) · Lafia Journal of Scientific and industrial Research · doi:10.62050/ljsir2026.v4n1.824
Mojarrad, P., Tiainen, H., Tammela, P., Laaksonen, T., Kiljunen, S., & Gounani, Z. (2026) · Research Square · doi:10.21203/rs.3.rs-8986145/v1
Bakó, C. (2025) · Pécsi Egyetemi Archívum (University of Pécs)
Sisay, A. S., Asmare, Z., Getachew, E., Kassanew, B., Tamrat, E., Gashaw, Y., & Reta, M. A. (2026) · PHAGE · doi:10.1177/26416549261477852
Antibiotic resistance of Pseudomonas aeruginosa strains—intracellular metabolomics analysis
Mielko, K. A., Jabłoński, S. J., Wiśniewski, J. Ł., Milczewska, J., Sands, D., Łukaszewicz, M., & Młynarz, P. (2026) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf453
Ahmad, H., Shahin, F., Zubair, F., Maqbool, M. M., Nisar, M. S., Yasin, S., & Khan, A. K. (2025) · Sarhad Journal of Agriculture · doi:10.17582/journal.sja/2025/41.5.282.289
Ihab, M. A. (2026) · Journal of Science Research and Reviews · doi:10.70882/josrar.2026.v3i5.324
Antimicrobial Activity of Aromatic Herb Essential Oils against Pseudomonas aeruginosa
(2024) · International Journal of Veterinary Science · doi:10.47278/book.cam/2024.426
Dweh, T. J., & Rayanoothala, P. S. (2023) · Acta Botanica Plantae · doi:10.51470/abp.2023.02.03.07
Shafigh, M., Amoli, R. I., Pournajaf, A., Yahyapour, Y., & Kaboosi, H. (2024) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.18.5.319
Raouf, M. A. (2026) · JOURNAL OF COMMUNICABLE DISEASES · doi:10.24321/0019.5138.202625
Oteh, O. C., Anoh, R. E., & Udu-Ibiam, O. E. (2026) · International Journal of Medical Biological and Pharmaceutical Science · doi:10.70382/hijmbps.v12i3.026
Mikhlef, R. M., & Hmood, R. A. (2026) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2026.100793
Quorum Sensing and Genetic Lineages in Carbapenem-Resistant Pseudomonas aeruginosa
Shafigh, M., Pournajaf, A., Amoli, R. I., Yahyapour, Y., & Kaboosi, H. (2024) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-156576
Hernanda, M. D. A., Wandhara, S. A., Asmarawati, T. P., Effendi, W. I., & Widodo, A. D. W. (2024) · International Journal Of Scientific Advances · doi:10.51542/ijscia.v5i6.57
Identificación de genes de resistencia a carbapenémicos en Pseudomonas aeruginosa
González, C., Rodríguez-Ocampo, A. N., Ramos-Ramírez, P. E., Arvizu‐Gómez, J. L., & Ramos-Ramírez, L. (2025) · Revista Bio Ciencias · doi:10.15741/revbio.12.e1829
RESISTÊNCIA BACTERIANA DE PSEUDOMONAS AERUGINOSA EM INFECÇÕES HOSPITALARES
da Silva, I. E. S., Lopes, A. D. A. A. C., Gomez, I. A., Garcia, K. D. S., & de Oliveira, C. M. S. (2025) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v11i10.21415
Using Galleria mellonella to study pathogen dissemination and anti-infective surface coatingsPreprint
Maslova, E., Staber, C., & McCarthy, R. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.11.598455
COMPARISON OF ANTIBIOTIC SUSCEPTIBILITY TEST ON NUTRIENT AGAR AND MUELLER HINTON’S AGAR
Zahid, A., Aleem, B., & Khan, M. R. (2025) · BMC Journal of Medical Sciences · doi:10.70905/bmcj.06.02.0539
Research Progress of Peritoneal Dialysis-Associated Peritonitis Risk Factors
姜, 瑶. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.163910
Faris, G. Q., Karim, K. J., & Mustafa, H. K. (2026) · Science Journal of University of Zakho · doi:10.25271/sjuoz.2026.14.2.1660
Diagnosis and treatment of sternomediastinitis: A narrative review
А., М. Д., Владиславович, Х. В., Винокуров, И. А., & Tagabilev, D. G. (2026) · Consilium Medicum · doi:10.26442/20751753.2026.1.203526
Lourdu Pouline, S., Raj, T. L. S., Sarath Kumar, R., & Raja, P. (2026) · International Journal of Zoological Investigations · doi:10.33745/ijzi.2026.v12i01.089
Ferreres, G., Rathee, G., Biswas, T. T., Ivanova, K., Nierstrasz, V. A., & Tzanov, T. (2026) · ACS Omega · doi:10.1021/acsomega.6c02477
Nabetani, Y., Kuramochi, K., & Furuyama, Y. (2026) · Acta Microbiologica Hellenica · doi:10.3390/amh71030025
Möst, J., Hübl, A., Planz, V., & Windbergs, M. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127224
Potenciación de Antibióticos con Extracto de Thymus Vulgaris contra Pseudomona Aeruginosa in Vitro
Curiel, R. I. A., Vargas, G. A., & Rodríguez, J. R. M. (2026) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v10i3.24784
Jubair, N. K., Mogana, R., Khanna, K., Mahdi, Y. K., & Fatima, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-66945-9
Medical Aspects of Bacterial Stigmergy
Morozova, N. S., Marievsky, V. F., Коробкова, І. В., Golovchak, G. S., Popov, O., Balko, O. I., & Bаlko, O. B. (2026) · Mikrobiolohichnyi Zhurnal · doi:10.15407/microbiolj88.02.098
Rouamba, A., Bangré, Y. A., Ouedraogo, V., Compaoré, E., & Kiendrebeogo, M. (2026) · Malaysian Journal of Microbiology · doi:10.21161/mjm.230507
Rodrigues, Y. C., dos Santos, P. A. S., dos Santos, C. S., Sardinha, D. M., Diniz, A. F., Silva, B. N., Silva, J. V. D. S., Aires, C. A. M., Brasiliense, D. M., Lima, K. V. B., et al. (2026) · Pandemics · doi:10.3390/pandemics1030015
Queiroz, T. G. D. R., Nunes, R. B. B., de Melo, M. L. L. C., de Freitas, A. D. G., & Marçal, L. N. (2026) · Scientia Generalis · doi:10.22289/sg.v7n2a53
Queiroz, T. G. D. R., Nunes, R. B. B., de Melo, M. L. L. C., de Freitas, A. D. G., & Marçal, L. N. (2026) · Scientia Generalis
Rahman, R. A. A. E. (2026) · Journal of Pioneering Medical Science · doi:10.47310/jpms2026151015
Metadata
- Authors
- Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D.
- Affiliations
- Instituto de Salud Carlos III (ES)
- Venue
- Biofilm
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 5
- Pages
- 100129
- ISSN
- 2590-2075 (ISSN-L)
- PMC
- PMC10189392
- OpenAlex
- W4367693161
- Cited by
- 170
- References
- 136
- Citations by year
- 2026: 65 · 2025: 64 · 2024: 34 · 2023: 7
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- Biofilm (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Hispana (submittedVersion, cc-by-nc-nd)
- Funders
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (2322/2746)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Pseudomonas aeruginosa, biofilm, antibiotic resistance, spontaneous mutation rate, chronic infection, chronic lung infection, antimicrobial therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Fig. 1 Mechanisms of antimicrobial tolerance and resistance found in biofilms and antibiotics affected by them. FQ: Fluoroquinolones; AMG: Aminoglycosides; AZT: Azitromycin; LPS: lipopolysaccharide. Figure adapted from Ciofu O et al., Nat rev, 2022 [62].](https://figures.cochat.ai/paper-figures/9868f8e636334ecababe5458f56b6d16/mechanisms-of-antibiotic-resistance-in-pseudomonas-aeruginosa-biofilms-figure-1.jpg)